Branimir Cvetkovic

Accomplished cross-functional leader with a strong scientific background and commercial expertise, adept at applying both throughout various stages of the product lifecycle. Excelling in matrix organizations and similar dynamic environments by leveraging networking and collaboration to drive and manage diverse initiatives. Demonstrated track record as a self-starter and influential organizational leader in multiple organizations. Played a significant role in supporting development and product strategies for 30+ products, including most of Novartis Oncology portfolio over the past decade. Beyond product support, led and supported the establishment of initiatives aimed at creating differentiated assets across multiple portfolios. Notable examples include leadership in establishing the Oncology Early Lifecycle Team and Product Differentiation Planning at Novartis and creating Portfolio Prioritization & Device Development processes at Dr. Reddy's, among others. Co-led several corporate initiatives, including Project BLUE ($1B Novartis Portfolio Transformation), Project OCEAN (Novartis cross-divisional portfolio alignment), and Project ENGAGE (Novartis’ integrated evidence planning), to name a recent few. In-depth expertise in market access dynamics, regulations, and healthcare organizations in both the US and key global markets - knowledge needed to effectively navigate the complexities of bringing innovative products to market and achieving commercial success.